Polarean Imaging Share Discussion Threads

[amaretto1] 04/4/2024 13:19

It's all the sighns of it They had money offered at 15 pence It was refused They delist solves everything for the insiders Absolutely no doubt about that And give me one reason Why they won't do it ?

[henley2] 04/4/2024 13:15

Because the CEO is a complete tool.Instead of raising money when first appointed, he's allowed the share price to collapse to where it is today. This will probably either go bust or delist and allow Bracco to take the technology for peanuts. Van Jako gets paid out and Bastien given a lucrative fee to carry on research. Shareholders wiped out! AIMHO

[amaretto1] 04/4/2024 13:10

My strong opinion Like several companies recently on AIM Never seen it before They will de list and take it private Basically shafting current private shareholders Uk market is a ses pit

[goldbutler] 04/4/2024 12:31

The Board of Directors including Bracco representative director and Nukem
said that 9 conversions were planned for 2 years wave 1 and wave 2

Wholly inadequate for the company survival funded by 27 million pounds and more from AIM investors

On a monthly basis 28 people receive a very handsome pay cheque
and the CEO cannot bring himself to refer to shareholders

He never stops on Linkedin including references to a previous company

So where is the investor presentaion for AIM INVESTORS for wave 1 and 2

Wave 1 Wave 2
Ohio Texas
Missouri Iowa
N.Carolina Kansas
Virginia Illinois
Wisconsin


Where is the commercial strategy including partnerships for sales into UK and Europe and arab states where there is no shortage of cash and significant COPD problem.

Why would any board of directors behave like this and for 18 months warn and advise of a cash raise and see the share price destruction.

[moontheloon] 04/4/2024 08:07

Courtesy lsehttps://med.virginia.edu/radiology-research/research/hyperpolarized-gas-mr-imaging/Plenty of under the radar positives due out when red tape of budgets been navigated. This one has 2 branded polarean units so any conversion not necessarily just the one at these large multi discipline institutes. Keep the faith. One or two conversions taking us to 5 systems will see this over 10p... and back to sensible valuation

[riskyinvestor] 22/3/2024 10:51

Tower Resources (TRP) is the Stock to be in

[moontheloon] 22/3/2024 08:39

https://www.medimaging.net/mri/articles/294797497/cutting-edge-mri-system-incorporates-hyperpolarized-xenon-imaging-for-enhanced-lung-ventilation-assessment.html ..Just one of the partnerships and reasons why at current share price this is a big bargain buy. Not long now for news on all fronts .

[moontheloon] 19/3/2024 09:36

Does he? Hope so. Just Need the right news to get us moving now.

[wetdream] 19/3/2024 09:02

Sandy12345,
You have an uncanny knack of being right. 🤔

[moontheloon] 19/3/2024 08:30

Think we may still have a last chunk from amati in the system. Then selling pressure gone

[sandy12345] 19/3/2024 07:05

Added 150k yesterday, I believe we will see a run up to 8p and stabilise there very soon

[moontheloon] 14/3/2024 14:27

Bollix go and invest in a company Hatton once weight on share price has been removed. And news flow steady rectify to double figures. Then it's at a sensible valuation

[rhatton] 14/3/2024 14:21

So they’re looking for 3.5 mil from sources not mentioned.. so pi or other institutions?
What price are they going to want? Also Bracco nukem… have said they are interested but at what price?

2.5p?

[pre] 14/3/2024 14:16

Thanks timbo003

[timbo003] 14/3/2024 14:04

>>>pr

the company has stated that they will raise more cash and given estimates for quantity and timings (so that is in the price already), see feb 29th RNS

[pre] 14/3/2024 13:06

how much cash do they have left as it looks like a placing is coming?

[moontheloon] 14/3/2024 12:20

Bastiaan held through £10m value plus of shares to 200k. Not flinched. Says something

[moontheloon] 14/3/2024 12:09

They're in process. Red tape budgets. It's happening mark my words.

[wetdream] 14/3/2024 11:22

According to his bio:

‘Dr Driehuys returned to academia at Duke University, where he is now a Professor of Radiology, Medical Physics and Biomedical Engineering’

You’d think Duke would be a contracted customer already!

[moontheloon] 14/3/2024 11:00

Another step to amati going out of the hair. There will be a lot buying once they have gone it will start a steady rectifying. Duke and others due anytime amongst other newsflow

[dym turbo] 14/3/2024 09:47

Cherster, did you read the RNS from Amati this morning?

When you see Strategic Review in the title of an RNS on AIM you know there is a mess at play!

I can 100% guarantee you that Amait would not be selling their stake to Nukem at 5p when the 2 main Strategic Investors have confirmed they will back to company long term!

We all know Amati wanted the POLX sold last year and they also blocked the 40p fundraise in April! Mmmm, I wonder why??

I’m sorry to see Amati go and feel they have been an excellent investor to POLX over the years but that RNS this morning was peppering over the cracks of a horrendous few years for the them – end of story!

[chester9] 14/3/2024 09:00

Amati and Miton have seriously underperformed with the outflows from uk funds to funds with more global returns it may take longer yet for small companies to attract investment not least when 250 still cheap and being raided. It's a waiting game for the money to flow lower. Amati no longer waiting and much better bets than Polx. Polx running out of fans and cash, like many others.

[wetdream] 14/3/2024 08:50

Imho Amati deserve a lot of credit for supporting POLX over the years.
Like many investors in the company, they were misled by the overconfidence and inactivity of the BoD during the crucial post- CRL period.
Add to that the fact that AIM’s become a graveyard for small biotech and medtech companies and you have a perfect storm.
Top it all off with an exclusive US-centric strategy with an inadequate infrastructure to implement it and you can see why they are where they are.

[moontheloon] 14/3/2024 08:41

Its just the obvious delays from perceptions to reality . Medical always takes longer. But polx have achieved goals but slightly slower . Ie fda longer now going for an extra fda. Scope gets bigger. Highly supportive shareholders and nukem who have insider info happy to take shares.

[rhatton] 14/3/2024 08:34

Could another way to look at this be that Amati have made some bad calls over the last few years… they were polareans biggest investor as they felt this was going to be the next best thing. SED delisted.. what makes you think Polx isn’t just another one of their bad calls?

Also I’m not sure from a trading point of view this was a bad call between listing and October 2021, this was doing fantastically well until the CRL. Raising bigger quantities of money at higher prices backed up by progress at that time.. and then boom